🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › South Carolina

Chronic Lymphocytic Leukemia clinical trials in South Carolina

5 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in South Carolina.

Cities in South Carolina

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AnMed Health Cancer Center, Anderson
  • Prisma Health Richland Hospital, Columbia
  • McLeod Regional Medical Center, Florence
  • and 12 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Ralph H Johnson VA Medical Center, Charleston
  • Medical University of South Carolina, Charleston
  • and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT04269902

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  • Medical University of South Carolina, Charleston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06973187

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Bon Secours St. Francis Cancer Center, Greenville
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

  • Hollings Cancer Center at Medical University of South Carolina, Charleston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT05702853

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.